← Eichor
Condition: Risk Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Risk

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The DistaSense VITALS Study
Phase N/A · 2 location(s) · Life Detection Technologies · NCT07217327S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
Phase 2 · 1 location(s) · Ivan de Kouchkovsky, MD · NCT06384222A Food As Medicine Approach to Address Food Insecurity in Rural North Carolina
NA · 1 location(s) · North Carolina State University · NCT07221045Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06629207Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
Phase 2 · 3 location(s) · University of California, San Diego · NCT06624475The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Phase 2 · 4 location(s) · Yale University · NCT06111781Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
NA · 1 location(s) · University of Massachusetts, Worcester · NCT06223867Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk R
Phase 2 · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07239245Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Phase 2/Phase 3 · 50 location(s) · Airway Therapeutics, Inc. · NCT06897839Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-relat
Phase N/A · 1 location(s) · Air Force Military Medical University, China · NCT06118437A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considerin
NA · 1 location(s) · Columbia University · NCT05963971uSafeUS+ App Pilot Testing
NA · 2 location(s) · University of Florida · NCT07557745The Muscle Monitor: Early Skeletal Muscle Indicators of Insulin Resistance and Cardiometabolic Risk
Phase N/A · 1 location(s) · University Ghent · NCT07678736Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Phase 2 · 1 location(s) · University of Rochester · NCT05597345Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Phase N/A · 1 location(s) · Steno Diabetes Center Copenhagen · NCT05890365Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts
Phase N/A · 1 location(s) · University of Michigan · NCT06508892Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )
NA · 20 location(s) · University Hospital, Brest · NCT06731244Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Uppe
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT05775471Mental Health in Primary Care
NA · 17 location(s) · University of Miami · NCT05426057Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05879965Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Phase 2 · 1 location(s) · New York Medical College · NCT07013565Genetic and Environmental Risk Factors for Hemorrhagic Stroke
Phase N/A · 7 location(s) · State University of New York at Buffalo · NCT00682695Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05443412Wear and Tear on Military Personnel Post Caledonian Crisis
Phase N/A · 1 location(s) · Direction Centrale du Service de Santé des Armées · NCT06907030Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
Phase 3 · 9 location(s) · Uppsala University · NCT04722692Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment
Phase N/A · 3 location(s) · HJN Sverige AB/Neko Health · NCT06984211Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · 35 location(s) · University College, London · NCT03288532
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.